Olympus Stock Performance
| OCPNF Stock | USD 16.00 0.00 0.00% |
The company holds a Beta of 0.58, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Olympus' returns are expected to increase less than the market. However, during the bear market, the loss of holding Olympus is expected to be smaller as well. At this point, Olympus has a negative expected return of -0.13%. Please make sure to check Olympus' total risk alpha, and the relationship between the standard deviation and kurtosis , to decide if Olympus performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Olympus has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders. ...more
| Begin Period Cash Flow | 217.5 B | |
| Total Cashflows From Investing Activities | -71 B |
Olympus |
Olympus Relative Risk vs. Return Landscape
If you would invest 1,765 in Olympus on September 1, 2024 and sell it today you would lose (165.00) from holding Olympus or give up 9.35% of portfolio value over 90 days. Olympus is currently producing negative expected returns and takes up 2.0847% volatility of returns over 90 trading days. Put another way, 18% of traded pink sheets are less volatile than Olympus, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Olympus Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Olympus' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Olympus, and traders can use it to determine the average amount a Olympus' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0641
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | OCPNF |
Estimated Market Risk
| 2.08 actual daily | 18 82% of assets are more volatile |
Expected Return
| -0.13 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Olympus is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Olympus by adding Olympus to a well-diversified portfolio.
Olympus Fundamentals Growth
Olympus Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Olympus, and Olympus fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Olympus Pink Sheet performance.
| Return On Equity | 0.23 | |||
| Return On Asset | 0.0815 | |||
| Current Valuation | 25.72 B | |||
| Shares Outstanding | 1.27 B | |||
| Price To Earning | 29.76 X | |||
| Price To Book | 5.27 X | |||
| Price To Sales | 0.03 X | |||
| Revenue | 868.87 B | |||
| EBITDA | 219.64 B | |||
| Cash And Equivalents | 299.09 B | |||
| Cash Per Share | 234.94 X | |||
| Total Debt | 333.85 B | |||
| Debt To Equity | 0.68 % | |||
| Book Value Per Share | 400.75 X | |||
| Cash Flow From Operations | 169.73 B | |||
| Earnings Per Share | 0.75 X | |||
| Total Asset | 1.36 T | |||
| Retained Earnings | 189.37 B | |||
| Current Asset | 464.59 B | |||
| Current Liabilities | 250.83 B | |||
About Olympus Performance
By analyzing Olympus' fundamental ratios, stakeholders can gain valuable insights into Olympus' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Olympus has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Olympus has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Olympus Corporation manufactures and sells precision machineries and instruments worldwide. Olympus Corporation was incorporated in 1919 and is headquartered in Tokyo, Japan. Olympus Corp operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 31557 people.Things to note about Olympus performance evaluation
Checking the ongoing alerts about Olympus for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Olympus help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Olympus generated a negative expected return over the last 90 days | |
| About 60.0% of the company shares are owned by institutional investors |
- Analyzing Olympus' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Olympus' stock is overvalued or undervalued compared to its peers.
- Examining Olympus' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Olympus' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Olympus' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Olympus' pink sheet. These opinions can provide insight into Olympus' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Olympus Pink Sheet analysis
When running Olympus' price analysis, check to measure Olympus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Olympus is operating at the current time. Most of Olympus' value examination focuses on studying past and present price action to predict the probability of Olympus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Olympus' price. Additionally, you may evaluate how the addition of Olympus to your portfolios can decrease your overall portfolio volatility.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |